415
Views
0
CrossRef citations to date
0
Altmetric
Review

FUS gene mutation in amyotrophic lateral sclerosis: a new case report and systematic review

, , , , & ORCID Icon
Pages 1-15 | Received 27 Jul 2023, Accepted 08 Oct 2023, Published online: 05 Nov 2023

References

  • Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:a024117.
  • Berjaoui S, Povedano M, Garcia-Esparcia P, Carmona M, Aso E, Ferrer I. Complex inflammation mRNA-related response in ALS is region dependent. Neural Plast. 2015;2015:573784.
  • Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
  • Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362.
  • Chia R, Chiò A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94–102.
  • Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208–11.
  • Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic. 2006;5:8–14.
  • Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.
  • Eura N, Sugie K, Suzuki N, Kiriyama T, Izumi T, Shimakura N, et al. A juvenile sporadic amyotrophic lateral sclerosis case with P525L mutation in the FUS gene: a rare co-occurrence of autism spectrum disorder and tremor. J Neurol Sci. 2019;398:67–8.
  • Lanteri P, Meola I, Canosa A, De Marco G, Lomartire A, Rinaudo MT, et al. The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment. Neurobiol Aging. 2021;103:130.e1–130.e7.
  • Picher-Martel V, Brunet F, Dupré N, Chrestian N. The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature. J Child Neurol. 2020;35:556–62.
  • Hirayanagi K, Sato M, Furuta N, Makioka K, Ikeda Y. Juvenile-onset sporadic amyotrophic lateral sclerosis with a frameshift FUS gene mutation presenting unique neuroradiological findings and cognitive impairment. Intern Med. 2016;55:689–93.
  • Tarlarini C, Lunetta C, Mosca L, Avemaria F, Riva N, Mantero V, et al. Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis. Eur J Neurol. 2015;22:1474–81.
  • Zhou B, Wang H, Cai Y, Wen H, Wang L, Zhu M, et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav. 2020;10:e01625.
  • Wu Y, Li C, Yang T, Lin J, Shang H. A case of juvenile-onset amyotrophic lateral sclerosis with a de novo frameshift FUS gene mutation presenting with bilateral abducens palsy. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:313–4.
  • Mochizuki Y, Isozaki E, Takao M, Hashimoto T, Shibuya M, Arai M, et al. Familial ALS with FUS P525L mutation: two Japanese sisters with multiple systems involvement. J Neurol Sci. 2012;323:85–92.
  • Mochizuki Y, Kawata A, Maruyama H, Homma T, Watabe K, Kawakami H, et al. A Japanese patient with familial ALS and a p.K510M mutation in the gene for FUS (FUS) resulting in the totally locked-in state. Neuropathology. 2014;34:504–9.
  • Yan J, Deng HX, Siddique N, Fecto F, Chen W, Yang Y, et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology. 2010;75:807–14.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
  • Chio A, Restagno G, Brunetti M, Ossola I, Calvo A, Mora G, et al. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging. 2009;30:1272–5.
  • Ticozzi N, Silani V, LeClerc AL, Keagle P, Gellera C, Ratti A, et al. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology. 2009;73:1180–5.
  • Belzil VV, Valdmanis PN, Dion PA, Daoud H, Kabashi E, Noreau A, et al. Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology. 2009;73:1176–9.
  • Tateishi T, Hokonohara T, Yamasaki R, Miura S, Kikuchi H, Iwaki A, et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 2010;119:355–64.
  • Groen EJ, van Es MA, van Vught PW, Spliet WG, van Engelen-Lee J, de Visser M, et al. FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol. 2010;67:224–30.
  • DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, et al. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat. 2010;31:E1377–E89.
  • Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, et al. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2010;67:455–61.
  • Kobayashi Z, Tsuchiya K, Arai T, Aoki M, Hasegawa M, Ishizu H, et al. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis. J Neurol Sci. 2010;293:6–11.
  • Rademakers R, Stewart H, Dejesus-Hernandez M, Krieger C, Graff-Radford N, Fabros M, et al. Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:170–6.
  • Robertson J, Bilbao J, Zinman L, Hazrati LN, Tokuhiro S, Sato C, et al. A novel double mutation in FUS gene causing sporadic ALS. Neurobiol Aging. 2011;32:527–53.
  • Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 2010;20:1069–76.
  • Chio A, Calvo A, Moglia C, Ossola I, Brunetti M, Sbaiz L, et al. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol Aging. 2011;32:523–53.
  • Yamamoto-Watanabe Y, Watanabe M, Okamoto K, Fujita Y, Jackson M, Ikeda M, et al. A Japanese ALS6 family with mutation R521C in the FUS/TLS gene: a clinical, pathological and genetic report. J Neurol Sci. 2010;296:59–63.
  • Waibel S, Neumann M, Rabe M, Meyer T, Ludolph AC. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology. 2010;75:815–7.
  • Baumer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611–8.
  • Mackenzie IR, Ansorge O, Strong M, Bilbao J, Zinman L, Ang LC, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87–98.
  • Syriani E, Morales M, Gamez J. FUS/TLS gene mutations are the second most frequent cause of familial ALS in the Spanish population. Amyotroph Lateral Scler. 2011;12:118–23.
  • Kono S, Ouchi Y, Terada T, Suzuki M, Yagi S, Miyajima H. Combined FDG and raclopride PET study in a case of ALS with the R521C FUS gene mutation. J Neurol. 2012;259:367–9.
  • Conte A, Lattante S, Zollino M, Marangi G, Luigetti M, Del GA, et al. P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul Disord. 2012;22:73–5.
  • Ito H, Fujita K, Nakamura M, Wate R, Kaneko S, Sasaki S, et al. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol. 2011;121:555–7.
  • Sproviero W, La Bella V, Mazzei R, Valentino P, Rodolico C, Simone IL, et al. FUS mutations in sporadic amyotrophic lateral sclerosis: clinical and genetic analysis. Neurobiol Aging. 2012;33:831–7.
  • Yamashita S, Mori A, Sakaguchi H, Suga T, Ishihara D, Ueda A, et al. Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation. J Neurol. 2012;259:1039–44.
  • Belzil VV, Langlais JS, Daoud H, Dion PA, Brais B, Rouleau GA. Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. Arch Neurol. 2012;69:653–6.
  • Zou ZY, Peng Y, Feng XH, Wang XN, Sun Q, Liu MS, et al. Screening of the FUS gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin. Eur J Neurol. 2012;19:977–83.
  • Nagayama S, Minato-Hashiba N, Nakata M, Kaito M, Nakanishi M, Tanaka K, et al. Novel FUS mutation in patients with sporadic amyotrophic lateral sclerosis and corticobasal degeneration. J Clin Neurosci. 2012;19:1738–9.
  • Zou ZY, Cui LY, Sun Q, Li XG, Liu MS, Xu Y, et al. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol Aging. 2013;34:1311–2.
  • Waibel S, Neumann M, Rosenbohm A, Birve A, Volk AE, Weishaupt JH, et al. Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany. Eur J Neurol. 2013;20:540–6.
  • Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Traynor BJ, et al. De novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol Aging. 2014;35:1513–7.
  • Mochizuki Y, Kawata A, Hashimoto T, Akiyama H, Kawakami H, Komori T, et al. An autopsy case of familial amyotrophic lateral sclerosis with FUS R521G mutation. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:305–8.
  • Kent L, Vizard TN, Smith BN, Topp SD, Vance C, Gkazi A, et al. Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:557–62.
  • Kim YE, Oh KW, Kwon MJ, Choi WJ, Oh SI, Ki CS, et al. De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36:1604–17.
  • King A, Troakes C, Smith B, Nolan M, Curran O, Vance C, et al. ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation. Acta Neuropathol Commun. 2015;3:62.
  • Zou ZY, Liu MS, Li XG, Cui LY. Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression. Ann Transl Med. 2015;3:221.
  • Agarwal S, Potocki L, Collier TR, Woodbury SL, Adesina AM, Jones J, et al. Utility of whole exome sequencing in evaluation of juvenile motor neuron disease. Muscle Nerve. 2016;53:648–52.
  • Zou ZY, Liu MS, Li XG, Cui LY. Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:249–52.
  • Leblond CS, Webber A, Gan-Or Z, Moore F, Dagher A, Dion PA, et al. De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol Genet. 2016;2:e63.
  • Aizawa H, Hideyama T, Yamashita T, Kimura T, Suzuki N, Aoki M, et al. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation. J Clin Neurosci. 2016;32:128–9.
  • Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, et al. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China. Sci Rep. 2016;6:32478.
  • Corcia P, Danel V, Lacour A, Beltran S, Andres C, Couratier P, et al. A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:298–301.
  • Gromicho M, Oliveira Santos M, Pinto A, Pronto-Laborinho A, De Carvalho M. Young-onset rapidly progressive ALS associated with heterozygous FUS mutation. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:451–3.
  • Liu ZJ, Lin HX, Liu GL, Tao QQ, Ni W, Xiao BG, et al. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet. 2017;92:267–73.
  • Kuang L, Kamelgarn M, Arenas A, Gal J, Taylor D, Gong W, et al. Clinical and experimental studies of a novel P525R FUS mutation in amyotrophic lateral sclerosis. Neurol Genet. 2017;3:e172.
  • Hikiami R, Yamakado H, Tatsumi S, Ayaki T, Hashi Y, Yamashita H, et al. Amyotrophic lateral sclerosis after receiving the human papilloma virus vaccine: a case report of a 15-year-old girl. Intern Med. 2018;57:1917–9.
  • Yu X, Zhao Z, Shen H, Bing Q, Li N, Hu J. Clinical and genetic features of patients with juvenile amyotrophic lateral sclerosis with fused in sarcoma (FUS) mutation. Med Sci Monit. 2018;24:8750–7.
  • Larner AJ, Fratalia L. Focal limb weakness (monoparesis): when family history holds the key to diagnosis. Br J Hosp Med. 2019;80:110–1.
  • Dodd KC, Power R, Ealing J, Hamdalla H. FUS-ALS presenting with myoclonic jerks in a 17-year-old man. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:278–80.
  • Naumann M, Peikert K, Gunther R, van der Kooi AJ, Aronica E, Hubers A, et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2019;6:2384–94.
  • Flies CM, Veldink JH. Chorea is a pleiotropic clinical feature of mutated fused-in-sarcoma in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:309–11.
  • Wongworawat YC, Liu YA, Raghavan R, White CL, Dietz R, Zuppan C, et al. Aggressive FUS-mutant motor neuron disease without profound spinal cord pathology. J Neuropathol Exp Neurol. 2020;79:365–9.
  • Chen L, Li J, Lu H, Liu Y. A de novo c.1509dupA:p.R503fs mutation of FUS: report of a girl with sporadic juvenile amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:635–7.
  • Zou ZY, Che CH, Feng SY, Fang XY, Huang HP, Liu CY. Novel FUS mutation Y526F causing rapidly progressive familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:73–9.
  • Moglia C, Calvo A, Brunetti M, Chio A, Grassano M. Broadening the clinical spectrum of FUS mutations: a case with monomelic amyotrophy with a late progression to amyotrophic lateral sclerosis. Neurol Sci. 2021;42:1207–9.
  • Tanemoto M, Hisahara S, Ikeda K, Yokokawa K, Manabe T, Tsuda R, et al. Sporadic amyotrophic lateral sclerosis due to a FUS P525L mutation with asymmetric muscle weakness and anti-ganglioside antibodies. Intern Med. 2021;60:1949–53.
  • Bodur M, Toker RT, Başak AN, Okan MS. A rare case of juvenile amyotrophic lateral sclerosis. Turk J Pediatr. 2021;63:495–9.
  • Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J. Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci 2019;20:2616.
  • Boylan K. Familial amyotrophic lateral sclerosis. Neurol Clin. 2015;33:807–30.
  • Zhou Y, Liu S, Liu G, Oztürk A, Hicks GG. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895.
  • Corrado L, Del Bo R, Castellotti B, Ratti A, Cereda C, Penco S, et al. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet. 2010;47:190–4.
  • Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010;29:2841–57.
  • Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ, et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010;19:4160–75.
  • Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13:686–99.
  • Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014;10:337–48.
  • Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4:99.
  • McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest. 2018;128:3558–67.
  • Sztainberg Y, Chen HM, Swann JW, Hao S, Tang B, Wu Z, et al. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature. 2015;528:123–6.
  • Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367–71.
  • Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med. 2022;28:104–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.